-
Information-Publications
-
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBDDetails
-
Creatine kinase brain-type regulates BCAR1 phosphorylation to facilitate DNA damage repairDetails
-
Base editing‐mediated perturbation of endogenous PKM1/2 splicing facilitates isoform‐specific functional analysis in vitro and in vivoDetails
-
A photoaffinity labeling strategy identified EF1A1 as a binding protein of cyclic dinucleotide 2′ 3′-cGAMPDetails
-
Safrana l Prevents Prostate Cancer Recurrence by Blocking the Re-activation of Quiescent Cancer Cells via Downregulation of S-Phase Kinase-AssociatedDetails
-
Proximity labeling reveals OTUD3 as a DNA-binding deubiquitinase of cGASDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands